ABL DIAGNOSTICS

- EUR (-)

- 15 min delayed data - Euronext Paris

Open:	-
Change:	-
Volume:	-

Low:	-
High:	-
High / Low range:	-

Type:	Stocks
Ticker:	ABLD
ISIN:	FR001400AHX6

ABL DIAGNOSTICS overview

> News Business Wire published a news.

ABL DIAGNOSTICS, Key Player in the Diagnosis of Infectious Diseases by Genotyping, Presents Its Development Plan to the Financial Community • • Business Wire • Stocks • More ABL DIAGNOSTICS news...

Regulatory News: ABL DIAGNOSTICS (Euronext Paris, FR001400AHX6, ABLD) today presents its ABLDX 2027 medium-term development plan to the financial community. Formed from the end-August 2022 merger of ABL France into the listed entity without activity ETABLISSEMENTS FAUVET-GIREL (renamed ABL DIAGNOSTICS), the company aims to be part of the Top 3 worldwide players in genotyping of pathogens linked to infectious diseases. A strategy based on proprietary expertise in sequencing processes The...

Thank you Chart

Load more content

Market scanning tools

See all Signals

Statistics

Analyses : 0
Followers : 0